NaviGate Cardiac Structures, Inc.
NaviGate Cardiac Structures, Inc., (NCSI) is an early-stage company focused on developing transcatheter solutions for the treatment of atrioventricular valve regurgitation. The NaviGate valve-based technology was licensed from Cleveland Clinic and further modified and developed by NCSI.
The GATE™ Valve
The NCSI Team
The leadership team at NCSI includes a core group of professionals with considerable experience and expertise in the development of surgical and transcatheter replacement heart valves. You can learn more about NCSI’s leadership team below.